Description: Gene therapy is a quickly evolving field and will continue to grow as a risk concern for many health plans, stop loss insurers and reinsurers. Currently, there are only two approved gene therapies in the U.S., but that number is expected to escalate starting in the fall of 2022. Revisit the experience plans have had with the first two gene therapies, discuss plan design and network considerations in light of gene therapy, and discuss the actual composition of the near-term pipeline along with a range of modeled financial impacts and considerations for payers.

Description: Investigate the concept of value annuities and the potential cost-effective differences when compared to traditional annuities by attending this webcast. Value annuities are an alternative lifetime income solution where longevity and investment risks are born by a pool of annuitants rather than a centralized insurer. Join this webcast for a closer look at the practicalities of designing and administering a value pool. There will also be a focus on the legislative, regulator and supervisory implications.

Description: Session 4E: Sometimes The Second is Better than the First - Round 2 for the ACA

Description: Hear a presentation of the American Academy of Actuaries Climate Change Joint Committee's paper, "Financial Inequities Caused by Climate-related Disasters". Climate equity will be achieved when the unequal burdens worsened by climate change on disadvantaged populations and the communities in which they live are recognized and addressed. These disadvantaged populations include lower-income groups, children, the disabled, and the elderly, and are they often rural.

Description: This session will present the results of a case study investigating the impact of genetic testing on the reduction of health care costs. This will present both actuarial and clinical analysis of genetic testing in addition to researchers who are applying this approach.

Description: The Medicare Advantage (MA) program is facing challenges in the coming years due to a number of headwinds: Star rating program changes, the Inflation Reduction Act (IRA), revenue pressures, mergers/acquisitions, and risk score model changes, just to name a few.

Description: "Advancing health equity is one of the five strategic objectives outlined in the CMS Innovation Center's strategic objectives for the next ten years and is an increasing area of focus across many states. Focus in on recent developments in addressing Medicaid beneficiary needs related to social determinants of health (SDOH), health-related social needs (HRSN), and health disparities and inequities in Medicaid. Several states have introduced non-traditional benefits into their programs in recent years to address these areas, such as various types of housing supports, nutrition-related benefits, and enhanced/advanced case management support. Expect a discussion on the benefits introduced recently in states such as AZ, CA, MA, NC, and OR, including funding considerations around these benefits as well as the 1115 demonstration waiver authorities granted to these states to allow coverage for these non-traditional health care services.

Description: The American Academy of Actuaries Health Solvency Subcommittee and the NAIC Health Risk-Based Capital (E) Working Group are in the process of analyzing and reviewing the H2-Underwriting Risk component and the managed care credit calculation in the health risk-based capital (HRBC) formula. Come learn what changes are ahead! While RBC is designed for solvency issues, also come hear about other ways health insurers manage their capital and surplus levels. Are others doing something you should try?

Description: 2024 is the 50th anniversary of ERISA and enough time has passed since the enactment of Secure 2.0. The U.S. Retirement system is mostly defined contribution. Gaps remain in U.S. Retirement Security and there are very different perspectives on how the system is doing. What is going well and what is not? Have plan sponsors capitalized on the opportunities in Secure 2.0?

Description: With the 2024 presidential election one week in the rear-view mirror, actuaries and health policy experts will discuss the potential health policy implications in the next four years in relation to the election results. Focus will be on the changing dynamics within Affordable Care Act (ACA) marketplaces with the knowledge benefit of the next president having administrative experience in the ACA environment. Session attendees will be well-equipped to discuss the post-ACA health policy implementation of presidents Biden and Trump, recent policy proposals, and potential legislative/regulatory changes as a result of the 2024 election outcomes.